SecBot SecBot
SECBOTREPLAY Home › Report › QURE

QURE · uniQure's CEO and CMO sold ~$2.9M in open-market sales within days of a…

uniQure N.V. · CLUSTER filed Jul 2, 2026 at 16:59 ET

At the news

MIXEDIMPACT 5/10

CLUSTER filed Jul 2, 2026 at 16:59 ET

uniQure's CEO and CMO sold ~$2.9M in open-market sales within days of a $225M public offering. The sales are modest relative to market cap (0.1%) but notable given the insider seniority and the proximity to the capital raise. The company recently announced FDA alignment for accelerated approval of its lead gene therapy, which tempers the bearish signal.

  • CEO Matthew Kapusta sold 28,700 shares at $50.02 for ~$1.44M on June 25, 2026.
  • CMO Walid Abi-Saab sold a total of ~31,434 shares across three trades (June 26 & 30) for ~$1.46M.
  • The insider selling cluster follows a $225M underwritten public offering priced at $45.50/share on June 23-24.
  • uniQure recently received FDA alignment to use Phase I/II data as primary basis for a BLA submission under accelerated approval for AMT-130.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access